Your browser doesn't support javascript.
loading
Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study.
Bo, Zhiyuan; Chen, Bo; Zhao, Zhengxiao; He, Qikuan; Mao, Yicheng; Yang, Yunjun; Yao, Fei; Yang, Yi; Chen, Ziyan; Yang, Jinhuan; Yu, Haitao; Ma, Jun; Wu, Lijun; Chen, Kaiyu; Wang, Luhui; Wang, Mingxun; Shi, Zhehao; Yao, Xinfei; Dong, Yulong; Shi, Xintong; Shan, Yunfeng; Yu, Zhengping; Wang, Yi; Chen, Gang.
Afiliação
  • Bo Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Chen B; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Zhao Z; Department of Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, P.R. China.
  • He Q; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Mao Y; Department of Optometry and Ophthalmology College, Wenzhou Medical University, Wenzhou, P.R. China.
  • Yang Y; Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Yao F; Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Yang Y; Department of Epidemiology and Biostatistics, School of Public Health and Management, Wenzhou Medical University, Wenzhou, P.R. China.
  • Chen Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Yang J; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Yu H; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Ma J; Department of Epidemiology and Biostatistics, School of Public Health and Management, Wenzhou Medical University, Wenzhou, P.R. China.
  • Wu L; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Chen K; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Wang L; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Wang M; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Shi Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Yao X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Dong Y; Department of Oncology, The Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, P.R. China.
  • Shi X; Department of Oncology, The Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, P.R. China.
  • Shan Y; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Yu Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
  • Wang Y; Department of Epidemiology and Biostatistics, School of Public Health and Management, Wenzhou Medical University, Wenzhou, P.R. China.
  • Chen G; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China.
Clin Cancer Res ; 29(9): 1730-1740, 2023 05 01.
Article em En | MEDLINE | ID: mdl-36787379
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article